ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Aspect Biosystems
The role involves designing and executing complex in vitro and ex vivo vascularization studies to develop bioengineered cellular medicines, analyzing data, and integrating findings into product design. The scientist will collaborate with cross‑functional teams, maintain rigorous experimental records, and support regulatory and IP deliverables.
Headquarters
Vancouver, British Columbia, Canada
Company Size
51-200 employees
Founded
2013
Aspect Biosystems is a biotechnology company pioneering bioprinted tissue therapeutics. Its full‑stack platform combines proprietary AI‑powered bioprinting, computational design tools, therapeutic cells, and advanced biomaterials to manufacture allogeneic implantable tissues. The company is developing a targeted pipeline focused on metabolic and endocrine diseases and partners with pharma and biotech to translate therapies to the clinic. A multidisciplinary team of scientists, engineers, and entrepreneurs drives its regenerative‑medicine efforts.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Aspect Biosystems.
44% above the average for this role